van Linde, Myra E <br/><br/>
Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme.  [electronic resource] 

 -  The oncologist  Feb 2015 
 - 107-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2014-0418  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bevacizumab--administration & dosage<br/>Brain Neoplasms--drug therapy<br/>Combined Modality Therapy<br/>Dacarbazine--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Temozolomide